India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
Gavi–UNICEF Deal Boosts Global Malaria Vaccination Why in the News? Gavi and UNICEF have signed a new procurement agreement to make the R21/Matrix-M malaria vaccine more affordable and widely available. This deal is expected to save $90 million and enable vaccination of nearly seven million additional children worldwide, addressing concerns about potential human rights violations …
Read MoreICMR Develops Promising New Malaria Vaccine Candidate Why in the News? The Indian Council of Medical Research (ICMR) has unveiled AdFalciVax, a potential malaria vaccine candidate offering over 90% protection in mice, with plans for further development and clinical trials, raising fresh hopes in the decades-long global malaria fight. AdFalciVax: A Breakthrough Against Malaria: AdFalciVax …
Read MoreIndia Develops Indigenous Multi-Stage Malaria Vaccine Why in News? India is developing AdFalciVax, a new malaria vaccine candidate targeting Plasmodium falciparum, the deadliest malaria parasite. Spearheaded by ICMR and DBT-NII, it aims to prevent clinical malaria episodes and community transmission, supporting India’s Make in India initiative and malaria elimination strategy. This development marks a significant …
Read MoreBHARAT BIOTECH TO SUPPLY GSK’S MALARIA VACCINE TO GAVI IN 2026 Why in the News? Strategic partnership: Bharat Biotech to supply RTS,S malaria vaccine, developed by GSK, to Gavi from 2026. Global milestone: RTS,S is the first malaria vaccine recommended by WHO in 2021. Gavi 6.0 phase: Supplies are part of commitments for …
Read MoreWhy in the news? The Serum Institute of India (SII) dispatched the first set of R21/Matrix-M malaria vaccine doses to Africa, marking a significant advancement in healthcare accessibility for the continent. source:scribd About R21/Matrix-M malaria vaccine: Development and Approval: The R21/Matrix-M vaccine, developed by the University of Oxford and the Serum Institute of India, received …
Read More
